| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/16/2006 | US20060035333 Transforming host expression cells with a shuttle vector containing a DNA encoding a fusion protein comprising a chitin-binding domain (CBD) and a target protein; gene expression and secretion; binding secreted fusion protein to chitin by means of CBD; chitin bead may be porous or magnetized |
| 02/16/2006 | US20060035332 Novel RFRP-3 and DNA thereof |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035330 Non aggregating fluorescent proteins and methods for using the same |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035327 with changed spatial configuration and improved efficacy; preventing or treating viral diseases; antitumor agents; also an artificial gene which codes for the interferon |
| 02/16/2006 | US20060035326 Genes |
| 02/16/2006 | US20060035325 Regulated apoptosis |
| 02/16/2006 | US20060035324 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/16/2006 | US20060035323 Method for producing sweetners and alcohol |
| 02/16/2006 | US20060035322 T-cell epitopes in erythropoietin |
| 02/16/2006 | US20060035321 Hydantoin racemase |
| 02/16/2006 | US20060035320 Immunoglobulin frameworks which demonstrate enhanced statbility in the intracellular envioronment and methods of identifying same |
| 02/16/2006 | US20060035319 Introducing DNA sequence encoding heterologous antigenic peptide; elicits immunogenic response; vaccine against cervical cancer |
| 02/16/2006 | US20060035318 Teneurin c-terminal associated peptides (tcap) and uses thereof |
| 02/16/2006 | US20060035317 Effect of treatment with 4,5-dihydroxy-2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 02/16/2006 | US20060035316 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035314 Receptors and signalling proteins capable of binding meiotic acting sterols (MAS) |
| 02/16/2006 | US20060035313 Proteolytic fermenter |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035286 Monitor protein for measuring processing of protein |
| 02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 02/16/2006 | US20060035242 Prion-specific peptide reagents |
| 02/16/2006 | US20060035230 Bacterial effector proteins which inhibit programmed cell death |
| 02/16/2006 | US20060035219 Aberrant kallikrein expression |
| 02/16/2006 | US20060035216 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 02/16/2006 | US20060034870 Increasing the immunogenicity of an antigen or a hapten by attaching it to an adjuvant having a fragment with a specific amino acid sequence of the P40 protein of Klebsiella pneumoniae to form an immunogenic complex |
| 02/16/2006 | US20060034866 Adipocyte complement related protein homolog zacrp3 |
| 02/16/2006 | US20060034853 Novel human virus causing respiratory tract infection and uses thereof |
| 02/16/2006 | US20060034850 Antibodies as T cell receptor mimics, methods of production and uses thereof |
| 02/16/2006 | US20060034830 Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform |
| 02/16/2006 | US20060034829 Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform |
| 02/16/2006 | US20060034828 glycoproteins; glycans; increased antibody-dependent cellular cytotoxicity (ADCC) activity; kits |
| 02/16/2006 | DE4229526B4 Vorrichtung zur Aufnahme und zum Einbringen von biologisch aktiven Geweben oder Zellen in den menschlichen Körper Device for receiving and for introducing biologically active tissues or cells in the human body |
| 02/16/2006 | DE19641213B4 Cyclische Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung Cyclic peptides, process for their preparation and their use |
| 02/16/2006 | CA2575769A1 Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1626084A1 Compositions and methods for the diagnosis of tumours |
| 02/15/2006 | EP1626058A1 Compositions and methods for the diagnosis of tumour |
| 02/15/2006 | EP1625219A1 Methods for producing secreted polypeptides |
| 02/15/2006 | EP1625209A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 02/15/2006 | EP1625208A2 Novel lipolytic enzyme lip2 |
| 02/15/2006 | EP1624891A2 Clotting factor-fc chimeric proteins to treat hemophilia |
| 02/15/2006 | EP1624883A2 Compositions and methods related to production of erythropoietin |
| 02/15/2006 | EP1624847A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 02/15/2006 | EP1624846A2 Inhibition of drug binding to serum albumin |
| 02/15/2006 | EP1624788A2 Use of endo180 receptor for diagnosis and treatment of disease |
| 02/15/2006 | EP1578802A4 Dna/rna transduction technology and its clinical and basic applications |
| 02/15/2006 | EP1481057B1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 02/15/2006 | EP1065269B1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
| 02/15/2006 | EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1735691A Fermentation process using specific oxygen uptake rates as a process control |
| 02/15/2006 | CN1735683A Methods and materials for the production of D-lactic acid in yeast |
| 02/15/2006 | CN1735433A Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 02/15/2006 | CN1735429A Coccidial vaccine and methods of making and using same |
| 02/15/2006 | CN1733929A Recombinant human composite alpha interferon preparation method |
| 02/15/2006 | CN1733928A Corn protein high F value oligopeptide production method |
| 02/15/2006 | CN1733910A Mononal antibody against avermectin, hybridoma cell line secreting the same and its preparation method |
| 02/15/2006 | CN1733806A Polypeptide random library and its construction method, and method for screening polypeptide capable of penetrating cell from the library |
| 02/15/2006 | CN1733799A Gene mutated archaerhodopsin 4 protein and its preparation method and uses |
| 02/15/2006 | CN1242055C Vancomycine producing fungus and its use |
| 02/15/2006 | CN1241944C Antibody againts 'alpha'-chain of human interleukin 5 receptor |
| 02/15/2006 | CN1241940C Novel collagen-like protein CLAC, Precursor thereof and genes encoding the same |
| 02/15/2006 | CN1241938C Purification technique in preparing genetic engineering vaccine of heat shock protein A of recombined Helicobacter pylori |
| 02/15/2006 | CN1241638C IFNAR2/I FN complex |
| 02/15/2006 | CN1241637C Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor |
| 02/15/2006 | CN1241489C Process of making high-concentration waste liquid of sodium glutamate convert into feedstuff protein |
| 02/14/2006 | US6998473 isolated polynucleotide molecules which encode the isoforms ; methods of screening compounds for vitamin D receptor (VDR) agonists and/or antagonists |
| 02/14/2006 | US6998472 Obesity gene |
| 02/14/2006 | US6998468 Anti-C2/C2a inhibitors of complement activation |
| 02/14/2006 | US6998467 diagnosing for and detection of carriers of the gene, Alzheimer's Disease diagnosis, gene therapy using recombinant technologies and therapy using the information derived from the DNA, protein, and the metabolic function of the protein |
| 02/14/2006 | US6998267 transformed plant cell is obtained by introducing to a plant cell a gene encoding a glycosyltransferase enzyme and a gene encoding an exogenous glycoprotein, cultivating the obtained transformed plant cell |
| 02/14/2006 | US6998260 DNA expression construct comprising, in 5' to 3' order: a promoter operationally linked to a secretion signal sequence, the secretion signal sequence operationally-linked to a DNA sequence encoding a proteolytic tryptase having active site mutation |
| 02/14/2006 | US6998259 preparing an aqueous solution of whey protein isolate and a proteolytic enzyme, holding solution under conditions effective to partially hydrolyze whey protein isolate to provide a hydrolysate having increased ACE-suppressing activity in mammals |
| 02/14/2006 | US6998254 Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis |
| 02/14/2006 | US6998245 Serine protease BSSP5 |
| 02/14/2006 | US6998242 Method of diagnosing metabolic bone diseases |
| 02/14/2006 | US6998234 Determining gene expression profile of vascular endothelial cells; obtain cells, incubate with immunological agent, isolate bound cells, extract ribonucleic acid sequences, expose to probe, monitor expression profile |
| 02/14/2006 | US6998108 Antibodies to p30 polypeptides and methods making and using same |
| 02/14/2006 | US6998042 Solid compositions for selective adsorption from complex mixtures |
| 02/14/2006 | CA1341496C Production of thrombin inhibitors |
| 02/09/2006 | WO2006015174A2 Detection of truncation mutations by mass spectrometry |
| 02/09/2006 | WO2006015057A2 C-terminally truncated interferon |
| 02/09/2006 | WO2006014899A2 Process for improved protein expression by strain engineering |
| 02/09/2006 | WO2006014493A2 Mechanically activated channel blocker |
| 02/09/2006 | WO2006013859A1 Yeast promoter |
| 02/09/2006 | WO2006013807A1 Arabinogalactan protein having activity of improving tolerance to heat or moisture stress |
| 02/09/2006 | WO2005118864A3 Antibodies and related molecules that bind to psca proteins |
| 02/09/2006 | WO2005108617A3 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 02/09/2006 | WO2005074647A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 02/09/2006 | WO2005069921A3 H. pylori fucosyltransferases |
| 02/09/2006 | WO2004032830A3 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 02/09/2006 | WO2003068923A3 Signal for packaging of influenza virus vectors |
| 02/09/2006 | WO2002097110A3 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060030527 Rage fusion proteins and methods of use |
| 02/09/2006 | US20060030521 Remodeling and glycoconjugation of peptides |